Spyryx Biosciences, Inc. — Form D
Spyryx Biosciences, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-12. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-12
- Form: D
- Accession: 0001633540-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 13
- Date of first sale: 2017-06-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-290488
Issuer
- Name: Spyryx Biosciences, Inc.
- CIK: 0001633540
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 801-10 CAPITOLA DRIVE, DURHAM, NC, 27713
- Phone: 919-899-9399
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Andrew Jordan | Director | Durham, NC |
| John Taylor | Director | San Jose, CA |
| John Taylor | Executive Officer | San Jose, CA |
| John Taylor | Promoter | San Jose, CA |
| Roger Jeffs | Director | Morrisville, NC |
| Christy Shaffer | Director | Durham, NC |
| Tim Shannon | Director | Westport, CT |
| Brian Daniels | Director | Villanova, PA |
| Timm Crowder | Executive Officer | Durham, NC |
| Timm Crowder | Promoter | Durham, NC |
| Robert Tarran | Director | Chapel Hill, NC |
| Andrew Jordan | Executive Officer | Durham, NC |
| Donald Rose | Director | Research Triangle Park, NC |
Other filings by this issuer (3)
More